drugset / Trial / NCT00535405

A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-128)

NCT00535405

RandomizedParallel-groupDouble-blindTreatment

Summary

A multicenter study to evaluate the safety and efficacy of ezetimibe/simvastatin versus atorvastatin in elderly patients with high cholesterol at high or moderately high risk for coronary heart disease.

Timeline

Start
2007-11
Primary completion
2009-03
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 10 mg
Subject Atorvastatin Small molecule 20 mg
Subject Atorvastatin Small molecule 40 mg
Subject Ezetimibe Unknown 10 mg
Subject Simvastatin Small molecule 20 mg
Subject Simvastatin Small molecule 40 mg

Indications